OR7E111P

Across TCGA pan-cancer cohorts, OR7E111P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR7E111P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher OR7E111P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR7E111P expression acts as an unfavorable survival marker, although some lineages such as OV and SKCM show a favorable association.

BRCA, UCEC, and KIRC are the cancer types where OR7E111P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.720	0.906	<.001	90	view →
UCEC	DFS	Tertile	All	0.535	0.664	.001	90	view →
KIRC	DFS	Tertile	II,III,IV	0.165	0.529	<.001	60	view →
OV	DFS	Tertile	III,IV	0.471	0.353	.014	54	view →
KIRP	OS	Tertile	III,IV	0.188	0.703	.005	36	view →
STAD	DFS	Tertile	II,III,IV	0.525	0.736	.015	30	view →
BLCA	OS	Tertile	IV	0.052	0.575	<.001	18	view →
SKCM	DFS	Tertile	II,III,IV	0.660	0.243	.011	18	view →
LUAD	DFS	Tertile	IV	0.671	0.893	.019	12	view →
HNSC	OS	Tertile	II,III,IV	0.156	0.423	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR7E111P–BRCA (DFS)

Open the BRCA breakdown →